Clinical trial
Study on CircRNA-Uck2 as a New Diagnostic Marker of Acute Myocardial Infarction
NCT03170830 is registered in ClinicalTrials.gov with Beijing Haidian Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on CircRNA-Uck2 as a New Diagnostic Marker of Acute Myocardial Infarction
- Lead sponsor
- Beijing Haidian Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 1, 2015
- Completion date
- December 31, 2018
- Enrollment
- 178 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction, cardiac disease, diagnoses disease